Pharmaceutical

Filter

Current filters:

None

Popular Filters

6801 to 6825 of 7182 results

Bayer still aims for top-10 position in Pharma

01-03-2012

Germany's Bayer (BAY: DE) is still confident that it can become a top-10 gobal pharmaceutical company,…

Markets & MarketingMergers & AcquisitionsPharmaceuticalResearch

Dainippon Sumitomo to acquire Boston Biomedical

01-03-2012

Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) says it has reached an agreement for the acquisition…

BiotechnologyMergers & AcquisitionsOncologyPharmaceutical

Forest Labs, Gedeon Richter plan 2012 filing for cariprazine

29-02-2012

Positive results from two phase III trials of Forest Laboratories and Gedeon Richter's new antipsychotic…

cariprazineForest LaboratoriesGedeon RichterHomeLexaproNamendaNeurologicalPharmaceutical

FDA expands on cholesterol-lowering drug risks

29-02-2012

Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins…

AstraZenecaCardio-vascularCrestorLipitorMerck & CoNorth AmericaPfizerPharmaceuticalRegulationZocor

Bayer achieved its targets in 2011, posing 4.1% sales rise

29-02-2012

Germany’s Bayer Group (BAY: DE) says it had a very successful year in 2011 both strategically and…

BayerFinancialPharmaceutical

Lundbeck buys remaining rights to desmoteplase from Paion

29-02-2012

Danish CNS drug specialist Lundbeck A/S (LUND: DC) and Germany’s Paion AG (FSE: PA8) have entered…

Cardio-vasculardesmoteplaseLundbeckMergers & AcquisitionsPaionPharmaceutical

Bayer and J&J’s Xarelto gets US Priority Review for new indication

29-02-2012

The US Food and Drug Administration has granted Priority Review designation to the supplemental New Drug…

BayerCardio-vascularJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationXarelto

Slower growth in Swiss economy will impact pharma, says BMI

28-02-2012

It is the view that the Swiss economy will record slower growth in 2012, says Business Monitor International…

EuropeMarkets & MarketingPharmaceutical

Merck warned for not carrying out post-approval sitagliptin study

28-02-2012

The US Food and Drug Administration (FDA) has sent a warning letter to Merck & Co for failing to carry…

DiabetesJanumetJanuviaMerck & CoPharmaceuticalRegulationsitagliptinSitagliptin Metformin HCL

Roche extends Illumina takeover deadline

28-02-2012

Roche has extended its $5.7 billion hostile takeover offer for genetic sequencing specialist Illumina…

HomeIlluminaMergers & AcquisitionsPharmaceuticalRoche

GSK inks $300m rare diseases alliance with Angiochem

28-02-2012

GlaxoSmithKline has forged an R&D alliance with Montreal, Canada-based Angiochem that will focus on the…

AngiochemCerezymeGenzymeGSKNeurologicalPharmaceuticalRare diseasesShireVpriv

New data support efficacy of Astellas' mirabegron for overactive bladder

28-02-2012

Astellas Pharma has reported the results of three separate clinical trials which further support the…

Astellas PharmaBetanisGenito-urinaryHomemirabegronPharmaceuticalVESIcare

Takeda's GPR40 agonist for diabetes promising in Ph II trial

28-02-2012

A Phase II trial of Takeda's GPR40 agonist TAK-875 published in The Lancet has found that the drug is…

DiabetesHomepeginesatidePharmaceuticalTAK-875Takeda Pharmaceuticals

GSK boss accuses UK government of blocking new drugs to save money

27-02-2012

The chief executive of the UK’s largest pharmaceutical company, GlaxoSmithKline (LSE: GSK) has accused…

EuropeGlaxoSmithKlineMarkets & MarketingPharmaceuticalPricingRegulation

Greek pharma sector bemoans accumulation of debts

27-02-2012

The Greek pharmaceutical industry association, the SFEE, says that pharmaceutical companies may go out…

EuropeFinancialHealthcarePharmaceuticalPolitics

No proof of added benefit for GlaxoSmithKline’s Trobalt, says IQWiG

27-02-2012

In another warning to drugmakers trying to get approval of new drugs under Germany’s AMNOG reform…

EuropeGlaxoSmithKlineNeurologicalPharmaceuticalPricingRegulationTrobalt

Forest Labs get EU appro for Colobreathe

27-02-2012

US drugmaker Forest Laboratories (NYSE: FRX) said on Friday that the European Medicines Agency has approved…

ColoBreatheColomycinEuropeForest LaboratoriesPharmaceuticalRare diseasesRegulation

Daiichi Sankyo and Terumo link up for vaccine development

27-02-2012

Drug major Daiichi Sankyo (TYO: 4568) and fellow Japanese company Terumo Corp (TYO: 4543) have entered…

Antibiotics and Infectious diseasesDaiichi SankyoPharmaceuticalResearchTerumoVaccines

Access Pharma’s MuGard OKed in China

26-02-2012

USA-based specialist in supportive care for cancer patients Access Pharmaceuticals (OTCBB: ACCP) revealed…

Access PharmaceuticalsAsia-PacificJain An PharmaceuticalsMuGardOncologyPharmaceuticalRegulationRhei Pharmaceuticals

Merck KGaA sets out efficiency program, with cost and job cuts likely

26-02-2012

Adding to the list of pharma companies announcing significant structural changes and job cuts, on Friday…

FinancialManagementMerck KGaAPharmaceutical

Quintiles to expand clinical development capabilities in Russia

26-02-2012

Biopharmaceutical services company Quintiles is moving further into emerging markets, last week signing…

EuropePharmaceuticalQuintilesRegulationResearchRVC Biofund

Herborium signs Lol to be acquired by China Health Resource

26-02-2012

New Jersey, USA-based botanical therapeutics company Herborium (Pink Sheets: HBRM) says it has signed…

China Health ResourceHerboriumMergers & AcquisitionsPharmaceutical

6801 to 6825 of 7182 results

Back to top